You are here

Canada House Cannabis Group Inc.

Listing Exchange: 
CSE
Status: 
Halted Pending Fundamental Change
Industry: 
Life Sciences
Symbol: 
CHV
CSE Index: 
Currency: 

Trading remains halted pending a fundamental change as described in Policy 8.  The corporate actions announced in this bulletin in no way represent Exchange approval, conditional or otherwise, of the fundamental change transaction.

Canada House Cannabis Group Inc. is the parent company of Abba Medix Corp., a Licensed Producer in Pickering, Ontario that produces high quality medical grade cannabis; Canada House Clinics Inc., clinics across the country that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from common to complex medical conditions; IsoCanMed Inc., a Licensed Producer in Louiseville, Quebec, that produces high quality medical grade cannabis; and Knalysis Technologies, a provider of fully customizable, cloud-based software that links physician, provider, and patient to data that supports treatment with medical cannabis.

 

 

You are here

Canada House Cannabis Group Inc. (CHV)

SEDAR Information

Company Info

Address
1773 Bayly Street
Pickering, ON L1W 2Y7
Canada
Phone
1-844-414-2911
Fax
1-844-414-2866
Email
info@canadahouse.ca
Website
http://www.canadahouse.ca
Listing date
Wednesday, November 9, 2016
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Steven Pearce
Email
ir@canadahouse.ca
Auditor
Ernst & Young Global Limited

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
22,788,427
Reserved for Issuance: 
19,907,308

Bulletins

29/08/2022

2022-0830 – Name Change and Consolidation - Canada House Wellness Group Inc. (CHV)

Le 29 août/August 2022

Canada House Wellness Group Inc. has announced a name change to Canada House Cannabis Group Inc. and a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 22,788,427 common shares.

The symbol will remain the same.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-12-07-Arcview-Access-Cannabis-Investment-Summit_Website.jpg

Arcview Access Cannabis Investment Summit

Wednesday, December 7, 2022 - 7:00pm to Friday, December 9, 2022 - 1:00pm